VIENNA, Va. (AP) _ Cel-Sci Corp. (CVM) on Tuesday reported a loss of $6 million in its fiscal third quarter.
The Vienna, Virginia-based company said it had a loss of 36 cents per share.
The cancer immunotherapy company posted revenue of $104,200 in the period. Its adjusted revenue was $104,000.
In the final minutes of trading on Tuesday, the company's shares hit $1.03. A year ago, they were trading at $3.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVM at https://www.zacks.com/ap/CVM